Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 37

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 37
---
ationskapital beträgt CHF 1‘819.44 und ist eingeteilt in 30‘324 Namenpartizipationsscheine (Vorzugspartizipationsscheine) mit einem Nennwert von je CHF 0.06. Das Partizipationskapital ist voll einbezahlt.                        
 […]                                                                                                                                                                                                                                             |     | The participation capital amounts to CHF 1,819.44 and is divided into 30,324 registered participation certificates (preferred participation certificates) with a nominal value of CHF 0.06 each. The participation capital is fully paid in.                                       
 […]”                                                                                                                                                                                                                                                                               |

•to increase the Company’s share capital by means of an ordinary capital increase as follows: (i)Nominal amount by which the share capital is to be increased: minimum of CHF 120,000 and maximum of CHF 240.000. (ii)Amount of contributions to be made thereon: 100% of the par value (fully paid -up). (iii)The number, par value and type of newly issued shares as well as any preferential rights attached to individual classes of shares: minimum of 1,500,000 and maximum of 3,500,000 registered NLS Common Shares, with a par value of CHF 0.06 each, no privileges attached. (iv)Issue price: The Board of Directors is authorized to determine the issue price. (v)Time of dividend entitlement: The new registered NLS Common Shares to be issued shall be entitled to dividends as of the date of registration of the capital increase in the Commercial Register. (vi)Type of contribution: Contribution in kind: 1 Kadimastem Ordinary Share. (vii) Transfer restrictions regarding the new registered shares: none. (viii) Restriction or cancellation of subscription rights and the consequences of subscription rights not exercised or withdrawn: The subscription rights of all shareholders in respect of this capital increase are cancelled because the new shares will be used for the settlement of the acquisition of all shares in Kadimastem under the Merger Agreement and the newly issued NLS Common Shares will be allocated to the (then former) shareholders of Kadimastem. The figures set above are not final numbers and may be adjusted once the reverse split ratio and Exchange Ratio are finalized. The decision on the reverse split ratio will be taken based on the market price of the NLS Common Shares immediately prior to the NLS Meeting. The